Related Experiment Video
Updated: Jul 19, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Methoxyflurane revisited: tale of an anesthetic from cradle to grave
1Stanford University School of Medicine, and Veterans Administration Palo Alto Health Care System, 300 Pasteur Drive, Stanford, CA 94305, USA. mazze@stanford.edu
Abstract:
Methoxyflurane metabolism and renal dysfunction: clinical correlation in man. By Richard I. Mazze, James R. Trudell, and Michael J. Cousins. Anesthesiology 1971; 35:247-52. Reprinted with permission. Serum inorganic fluoride concentration and urinary inorganic fluoride excretion were found to be markedly elevated in ten patients previously shown to have methoxyflurane induced renal dysfunction. Five patients with clinically evident renal dysfunction had a mean peak serum inorganic fluoride level (190 +/- 21 microm) significantly higher (P < 0.02) than that of those with abnormalities in laboratory tests only (106 +/- 17 microm). Similarly, patients with clinically evident renal dysfunction had a mean peak oxalic acid excretion (286 +/- 39 mg/24 h) significantly greater (P < 0.05) than that of those with laboratory abnormalities only (130 +/- 51 mg/24 h). That patients anesthetized with halothane had insignificant changes in serum inorganic fluoride concentration and oxalic acid excretion indicates that these substances are products of methoxyflurane metabolism. A proposed metabolic pathway to support this hypothesis is presented, as well as evidence to suggest that inorganic fluoride is the substance responsible for methoxyflurane renal dysfunction.
Insights
Methoxyflurane anesthesia can cause kidney damage. Elevated inorganic fluoride and oxalic acid levels in patients indicate methoxyflurane metabolism is linked to this renal dysfunction.
Area of Science:
- Anesthesiology
- Nephrology
- Toxicology
Background:
- Methoxyflurane is an inhalational anesthetic agent.
- Renal dysfunction is a potential adverse effect associated with methoxyflurane anesthesia.
- The metabolic pathways and toxic byproducts of methoxyflurane were not fully understood.
Discussion:
- Serum inorganic fluoride and urinary inorganic fluoride excretion were significantly elevated in patients with methoxyflurane-induced renal dysfunction.
- Patients with clinically evident renal dysfunction showed higher peak serum inorganic fluoride levels and oxalic acid excretion compared to those with only laboratory abnormalities.
Key Insights:
- Inorganic fluoride and oxalic acid are products of methoxyflurane metabolism.
- Inorganic fluoride is implicated as the causative agent in methoxyflurane-induced renal dysfunction.
- Halothane anesthesia did not result in similar elevations, supporting methoxyflurane as the source.
Outlook:
- Further research into the metabolic pathways of methoxyflurane is warranted.
- Understanding methoxyflurane's nephrotoxic mechanisms can inform safer anesthetic practices.
- Development of strategies to mitigate methoxyflurane-induced renal injury may be possible.
Related Concept Videos
Inhalational Anesthetics: Overview
Parenteral Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
